These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29055945)

  • 21. Invasive micropapillary carcinoma of the breast metastatic to the urinary bladder and endometrium: diagnostic pitfalls and review of the literature of tumors with micropapillary features.
    Ramalingam P; Middleton LP; Tamboli P; Troncoso P; Silva EG; Ayala AG
    Ann Diagn Pathol; 2003 Apr; 7(2):112-9. PubMed ID: 12715337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathological characteristics of ypT0N0 urothelial carcinoma following neoadjuvant chemotherapy and cystectomy.
    Magers MJ; Kaimakliotis HZ; Barboza MP; Bandali E; Adra N; Koch MO; Cheng L
    J Clin Pathol; 2019 Aug; 72(8):550-553. PubMed ID: 31164444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. USANZ: Time-trends in use and impact on outcomes of perioperative chemotherapy in patients treated with radical cystectomy for urothelial bladder cancer.
    Liew MS; Azad A; Tafreshi A; Eapen R; Bolton D; Davis ID; Sengupta S
    BJU Int; 2013 Nov; 112 Suppl 2():74-82. PubMed ID: 24127680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Outcomes of Patients with Histologic Variants of Urothelial Cancer Treated with Trimodality Bladder-sparing Therapy.
    Krasnow RE; Drumm M; Roberts HJ; Niemierko A; Wu CL; Wu S; Zhang J; Heney NM; Wszolek MF; Blute ML; Feldman AS; Lee RJ; Zietman AL; Shipley WU; Efstathiou JA
    Eur Urol; 2017 Jul; 72(1):54-60. PubMed ID: 28040351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bladder Metastasis from Breast Cancer: A Systematic Review.
    Karjol U; Jonnada P; Cherukuru S; Chandranath A
    Cureus; 2020 Mar; 12(3):e7408. PubMed ID: 32257726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinicopathological characteristics of muscle-invasive bladder recurrence in upper tract urothelial carcinoma.
    Shigeta K; Matsumoto K; Ogihara K; Murakami T; Anno T; Umeda K; Izawa M; Baba Y; Sanjo T; Shojo K; Tanaka N; Takeda T; Kosaka T; Mizuno R; Mikami S; Kikuchi E; Oya M
    Cancer Sci; 2021 Mar; 112(3):1084-1094. PubMed ID: 33368857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Late urinary bladder metastasis from breast cancer.
    De Rose AF; Balzarini F; Mantica G; Toncini C; Terrone C
    Arch Ital Urol Androl; 2019 Mar; 91(1):60-62. PubMed ID: 30932435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative analysis of the effect of prostatic invasion patterns on cancer-specific mortality after radical cystectomy in pT4a urothelial carcinoma of the bladder.
    Vallo S; Gilfrich C; Burger M; Volkmer B; Boehm K; Rink M; Chun FK; Roghmann F; Novotny V; Mani J; Brisuda A; Mayr R; Stredele R; Noldus J; Schnabel M; May M; Fritsche HM; Pycha A; Martini T; Wirth M; Roigas J; Bastian PJ; Nuhn P; Dahlem R; Haferkamp A; Fisch M; Aziz A
    Urol Oncol; 2016 Oct; 34(10):432.e1-8. PubMed ID: 27283218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence, Characteristics and Implications of Thromboembolic Events in Patients with Muscle Invasive Urothelial Carcinoma of the Bladder Undergoing Neoadjuvant Chemotherapy.
    Duivenvoorden WC; Daneshmand S; Canter D; Lotan Y; Black PC; Abdi H; van Rhijn BW; Fransen van de Putte EE; Zareba P; Koskinen I; Kassouf W; Traboulsi SL; Kukreja JE; Boström PJ; Shayegan B; Pinthus JH
    J Urol; 2016 Dec; 196(6):1627-1633. PubMed ID: 27312316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Radiochemotherapeutic options for bladder cancer].
    Weiss C; Sauer R; Rödel C
    Aktuelle Urol; 2008 Mar; 39(2):123-9. PubMed ID: 18379965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metastatic renal cell carcinoma to the urinary bladder: a report of 11 cases.
    Zhang M; Wah C; Epstein JI
    Am J Surg Pathol; 2014 Nov; 38(11):1516-21. PubMed ID: 25140895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trimodal therapy in T2-4aN0M0 bladder cancer--How to select the best candidate?
    Gofrit ON; Meirovitz A; Frank S; Rabinovich I; Luwisch H; Yutkin V; Neuman T; Hidas G; Duvdevani M; Wygoda M
    Cancer Med; 2020 Nov; 9(22):8491-8497. PubMed ID: 32960495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial.
    Sternberg CN; Skoneczna I; Kerst JM; Albers P; Fossa SD; Agerbaek M; Dumez H; de Santis M; Théodore C; Leahy MG; Chester JD; Verbaeys A; Daugaard G; Wood L; Witjes JA; de Wit R; Geoffrois L; Sengelov L; Thalmann G; Charpentier D; Rolland F; Mignot L; Sundar S; Symonds P; Graham J; Joly F; Marreaud S; Collette L; Sylvester R; ; ; ; ;
    Lancet Oncol; 2015 Jan; 16(1):76-86. PubMed ID: 25498218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative Effectiveness of Trimodal Therapy Versus Radical Cystectomy for Localized Muscle-invasive Urothelial Carcinoma of the Bladder.
    Seisen T; Sun M; Lipsitz SR; Abdollah F; Leow JJ; Menon M; Preston MA; Harshman LC; Kibel AS; Nguyen PL; Bellmunt J; Choueiri TK; Trinh QD
    Eur Urol; 2017 Oct; 72(4):483-487. PubMed ID: 28412065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical prognosticators of survival in patients with urothelial carcinoma of the bladder and lymph node metastases after cystectomy with curative intent.
    Horn T; Schmid SC; Seitz AK; Grab J; Wolf P; Haller B; Retz M; Maurer T; Autenrieth M; Kübler HR; Gschwend JE
    World J Urol; 2015 Jun; 33(6):813-9. PubMed ID: 25007992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer-specific mortality following radical cystectomy for bladder cancer with lymph node involvement: impact of pathologic disease features and adjuvant chemotherapy.
    Clifton MM; Psutka SP; Boorjian SA; Cheville JC; Thapa P; Thompson RH; Tollefson MK; Karnes RJ; Frank I
    World J Urol; 2015 Mar; 33(3):373-9. PubMed ID: 24833245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant chemotherapy is associated with decreased mortality after radical cystectomy for locally advanced bladder cancer.
    Yelfimov DA; Frank I; Boorjian SA; Thapa P; Cheville JC; Tollefson MK
    World J Urol; 2014 Dec; 32(6):1463-8. PubMed ID: 24420616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Neoadjuvant or Adjuvant Chemotherapy for Bladder Cancer?].
    Hupe MC; Kramer MW; Kuczyk MA; Merseburger AS
    Aktuelle Urol; 2015 May; 46(3):242-7. PubMed ID: 26077309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retrospective analysis of outcome in patients with nodal metastases from transitional cell carcinoma of lower urinary tract.
    Koch MO; Coussens DM
    Urology; 1994 Mar; 43(3):317-23. PubMed ID: 8134985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving the outcome for invasive bladder cancer: the debate regarding pelvic lymphadenectomy moves from if to how.
    Catto JW
    Eur Urol; 2011 May; 59(5):719-20. PubMed ID: 21367517
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.